Yidu Tech (2158) Announces Interim Results with Revenue Growth and Significant Reduction in Loss

Bulletin Express11-27

Yidu Tech (2158) reported interim results for the six months ended 30 September 2025, showing a revenue increase of 8.7% year-on-year to RMB358.1 million. Gross profit rose by 14.2% to RMB134.0 million, with overall gross margin improving from 35.6% to 37.4%. The loss for the period narrowed to RMB15.8 million, a 72.0% decrease compared with the same period last year, and operating loss dropped by 71.0% to RMB15.7 million.

In segment performance, Big Data Platform and Solutions grew by 14.6% and contributed RMB153.2 million. Life Sciences Solutions recorded RMB138.3 million, and Health Management Platform and Solutions rose 30.3% to RMB66.6 million. The company attributed its revenue growth to favorable policies and stronger market demand, helping boost overall order volumes.

During the reporting period, net cash outflow from operating activities decreased by 56.0% year-on-year. The company maintained total cash reserves (including cash and cash equivalents, term deposits, pledged and restricted deposits) of RMB2,099.3 million as of 30 September 2025. No interim dividend has been recommended.

Management highlighted ongoing investment in medical AI infrastructure and large-scale AI model deployment across healthcare, pharmaceuticals, and health insurance. The company plans to deepen its penetration in specialized disease areas and further integrate real-world data with advanced AI capabilities to drive efficiency in medical and research scenarios.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159936250?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 12:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159936250","market":"us","top_or_hot":-1,"title":"Yidu Tech (2158) Announces Interim Results with Revenue Growth and Significant Reduction in Loss","media":"Bulletin Express","content":"<p>Yidu Tech (2158) reported interim results for the six months ended 30 September 2025, showing a revenue increase of 8.7% year-on-year to RMB358.1 million. Gross profit rose by 14.2% to RMB134.0 million, with overall gross margin improving from 35.6% to 37.4%. The loss for the period narrowed to RMB15.8 million, a 72.0% decrease compared with the same period last year, and operating loss dropped by 71.0% to RMB15.7 million.</p>\n<p>In segment performance, Big Data Platform and Solutions grew by 14.6% and contributed RMB153.2 million. Life Sciences Solutions recorded RMB138.3 million, and Health Management Platform and Solutions rose 30.3% to RMB66.6 million. The company attributed its revenue growth to favorable policies and stronger market demand, helping boost overall order volumes.</p>\n<p>During the reporting period, net cash outflow from operating activities decreased by 56.0% year-on-year. The company maintained total cash reserves (including cash and cash equivalents, term deposits, pledged and restricted deposits) of RMB2,099.3 million as of 30 September 2025. No interim dividend has been recommended.</p>\n<p>Management highlighted ongoing investment in medical AI infrastructure and large-scale AI model deployment across healthcare, pharmaceuticals, and health insurance. The company plans to deepen its penetration in specialized disease areas and further integrate real-world data with advanced AI capabilities to drive efficiency in medical and research scenarios.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yidu Tech (2158) Announces Interim Results with Revenue Growth and Significant Reduction in Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYidu Tech (2158) Announces Interim Results with Revenue Growth and Significant Reduction in Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-27 12:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Yidu Tech (2158) reported interim results for the six months ended 30 September 2025, showing a revenue increase of 8.7% year-on-year to RMB358.1 million. Gross profit rose by 14.2% to RMB134.0 million, with overall gross margin improving from 35.6% to 37.4%. The loss for the period narrowed to RMB15.8 million, a 72.0% decrease compared with the same period last year, and operating loss dropped by 71.0% to RMB15.7 million.</p>\n<p>In segment performance, Big Data Platform and Solutions grew by 14.6% and contributed RMB153.2 million. Life Sciences Solutions recorded RMB138.3 million, and Health Management Platform and Solutions rose 30.3% to RMB66.6 million. The company attributed its revenue growth to favorable policies and stronger market demand, helping boost overall order volumes.</p>\n<p>During the reporting period, net cash outflow from operating activities decreased by 56.0% year-on-year. The company maintained total cash reserves (including cash and cash equivalents, term deposits, pledged and restricted deposits) of RMB2,099.3 million as of 30 September 2025. No interim dividend has been recommended.</p>\n<p>Management highlighted ongoing investment in medical AI infrastructure and large-scale AI model deployment across healthcare, pharmaceuticals, and health insurance. The company plans to deepen its penetration in specialized disease areas and further integrate real-world data with advanced AI capabilities to drive efficiency in medical and research scenarios.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02158","symbol_name":"医渡科技","start_time":0,"source_url":"","article_id":"1159936250","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159936250","pubTimestamp":1764217284,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Yidu Tech (2158) reported interim results for the six months ended 30 September 2025, showing a revenue increase of 8.7% year-on-year to RMB358.1 million. Gross profit rose by 14.2% to RMB134.0...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02158":"医渡科技"},"translate_title":"医渡科技(2158)公布中期业绩收入增长亏损大幅减少","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"Yidu Tech (2158) reported interim results for the six months ended 30 September 2025, showing a revenue increase of 8.7% year-on-year to RMB358.1 million. Gross profit rose by 14.2% to RMB134.0 million, with overall gross margin improving from 35.6% to 37.4%. The loss for the period narrowed to RMB15.8 million, a 72.0% decrease compared with the same period last year, and operating loss dropped by 71.0% to RMB15.7 million.\nIn segment performance, Big Data Platform and Solutions grew by 14.6% and contributed RMB153.2 million. Life Sciences Solutions recorded RMB138.3 million, and Health Management Platform and Solutions rose 30.3% to RMB66.6 million. The company attributed its revenue growth to favorable policies and stronger market demand, helping boost overall order volumes.\nDuring the reporting period, net cash outflow from operating activities decreased by 56.0% year-on-year. The company maintained total cash reserves (including cash and cash equivalents, term deposits, pledged and restricted deposits) of RMB2,099.3 million as of 30 September 2025. No interim dividend has been recommended.\nManagement highlighted ongoing investment in medical AI infrastructure and large-scale AI model deployment across healthcare, pharmaceuticals, and health insurance. The company plans to deepen its penetration in specialized disease areas and further integrate real-world data with advanced AI capabilities to drive efficiency in medical and research scenarios.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159936250","isCrawlerRequest":true}